ArticleHepatology communications2024

Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway.

Liangbo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.